High Prevalence of Undiagnosed Insulin Resistance in Non-Diabetic Subjects with Parkinson’s Disease

Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums

(2018) Steven E. Arnold et al.   Nature Reviews Neurology

Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial

(2017) Dilan Athauda et al.   LANCET

The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson's disease: mechanisms of action

(2016) Dilan Athauda et al.   DRUG DISCOVERY TODAY

Risk of Parkinson Disease in Diabetes Mellitus

(2016) Xuejing Yue et al.   MEDICINE

Body fat distribution in Parkinson's disease: An MRI-based body fat quantification study

(2016) Denise Bernhardt et al.   PARKINSONISM & RELATED DISORDERS

Alpha-synuclein overexpression negatively regulates insulin receptor substrate 1 by activating mTORC1/S6K1 signaling

(2015) Shanshan Gao et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Insulin resistance in brain alters dopamine turnover and causes behavioral disorders

(2015) Andre Kleinridders et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Weight gain and increased central obesity in the early phase of Parkinson's disease

(2014) Magdalena Vikdahl et al.   CLINICAL NUTRITION

Insulin resistance and gray matter volume in neurodegenerative disease

(2014) J.K. Morris et al.   NEUROSCIENCE

Dementia is associated with Insulin Resistance in patients with Parkinson's Disease

(2012) Domenico Bosco et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Metabolic markers or conditions preceding Parkinson's disease: A case-control study

(2012) Rodolfo Savica et al.   MOVEMENT DISORDERS

Clinical features of Parkinson disease when onset of diabetes came first: A case-control study

(2012) E. Cereda et al.   NEUROLOGY

Consumption of a high-fat diet induces central insulin resistance independent of adiposity

(2011) Deborah J. Clegg et al.   PHYSIOLOGY & BEHAVIOR

Systematic review of levodopa dose equivalency reporting in Parkinson's disease

(2010) Claire L. Tomlinson et al.   MOVEMENT DISORDERS

Optimal cut-off of homeostasis model assessment of insulin resistance (HOMA-IR) for the diagnosis of metabolic syndrome: third national surveillance of risk factors of non-communicable diseases in Iran (SuRFNCD-2007)

(2010) Alireza Esteghamati et al.   Nutrition & Metabolism

Insulin Resistance in Obese Children and Adolescents: HOMA-IR Cut-Off Levels in the Prepubertal and Pubertal Periods - Original Article

(2010) Selim Kurtoğlu et al.   Journal of Clinical Research in Pediatric Endocrinology

HOMA-beta in the UKPDS and ADOPT. Is the natural history of type 2 diabetes characterised by a progressive and inexorable loss of insulin secretory function? Maybe? Maybe not?

(2009) Gerald M. Reaven   Diabetes & Vascular Disease Research

Glucose Homeostasis in Huntington Disease

(2008) Nebojša M. Lalić et al.   ARCHIVES OF NEUROLOGY